BILLISHA ROBINSON
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ATLANTA, GA NPI 1407394166
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family GA Acerta Pharma LLC All categories
General Payments — all program years on this page
$5,813.06
- Category: General Payments
- Program years: PY2021–2024
- Record count: 217
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,721.56 across 62 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,649.57 | 61 |
| Education | $71.99 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $294.71 | 6 |
| Incyte Corporation | $196.70 | 5 |
| E.R. Squibb & Sons, L.L.C. | $153.21 | 3 |
| EISAI INC. | $129.14 | 6 |
| Celgene Corporation | $122.63 | 3 |
| ABBVIE INC. | $96.21 | 3 |
| Janssen Biotech, Inc. | $90.30 | 5 |
| SOBI, INC | $71.99 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $68.98 | 4 |
| Pharmacosmos Therapeutics Inc. | $66.05 | 4 |
| GENZYME CORPORATION | $65.54 | 3 |
| Merck Sharp & Dohme Corporation | $62.59 | 3 |
| ARRAY BIOPHARMA INC | $57.74 | 3 |
| Daiichi Sankyo Inc. | $52.99 | 3 |
| Gilead Sciences, Inc. | $41.81 | 2 |
| SERVIER PHARMACEUTICALS LLC | $24.71 | 1 |
| Mirati Therapeutics, Inc. | $23.00 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.70 | 1 |
| PFIZER INC. | $19.42 | 1 |
| Regeneron Healthcare Solutions, Inc. | $17.98 | 1 |
| TAIHO ONCOLOGY, INC. | $16.64 | 1 |
| Blueprint Medicines Corporation | $14.36 | 1 |
| EMD Serono, Inc. | $13.16 | 1 |
By program year
Records — PY2024 (62)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.